Intestinal Absorption and Disposition of Green Tea Catechins: The First Barrier for Green Tea Catechins Entering the Body

Tea in Health and Disease Prevention

Volumn , Issue , 2013, Pages 399-412

  Zuo, Zhong ^a   Zhang, Li ^a   Zhou, Limin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882881649     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384937-3.00033-1     Document Type: Chapter

References (46)

1. W. Andlauer, J. Kolb and P. Fürst (2000) Isoflavones from tofu are absorbed and metabolized in the isolated rat small intestine. J. Nutr. 130 3021-3027.
2. H.W. Bai, J.Y. Shim, J. Yu and B.T. Zhu (2007) Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem. Res. Toxicol. 20 1409-1425.
3. R. Benelli, R. Vene, D. Bisacchi, et al. (2002) Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo- and serine proteases. Biol. Chem. 383, 101-105.
4. K.Y. Chan, L. Zhang and Z. Zuo (2007) Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model. J. Pharm. Pharmacol. 59 395-400.
5. L. Chen, M.J. Lee, H. Li and C.S. Yang (1997) Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab. Dispo. 25 1045-1050.
6. H.-H.S. Chow, Y. Cai, D.S. Alberts, et al. (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenol E. Cancer Epidemiol. Biomarkers Prev. 10 53-58.
7. H.-H.S. Chow, I.A. Hakim, D.R. Vining, et al. (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res. 11 4627-4633.
8. V. Crespy, C. Morand, C. Manach, et al. (1999) Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am. J. Physiol. 277 G120-G126.
9. N.P. Das and L.A. Griffiths (1969) Studies on flavonoid metabolism. Metabolism of (+)-[14C] catechin in the rat and guinea pig. Biochem. J. 115 831-836.
10. M. Harada, Y. Kan, H. Naoki, et al. (1999) Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (−)-epicatechin. Biosci. Biotechnol. Biochem. 63 973-977.
11. T. Hirohashi, H. Suzuki and Y. Sugiyama (1999) Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J. Biol. Chem. 74 15181-15185.
12. J. Hong, J.D. Lambert, S.H. Lee, et al. (2003) Involvement of multidrug resistance-associated proteins in regulating cellular levels of (−)-epigallocatechin-3-gallate and its methyl metabolites. Biochem. Biophys. Res. Commun. 310 222-227.
13. J. Hong, H. Lu, X. Meng, J.H. Ryu, et al. (2002) Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 62 7241-7246.
14. M. Isemura, K. Saeki, T. Kimura, et al. (2000) Tea catechins and related polyphenols as anti-cancer agents. BioFactors 13 81-85.
15. S.K. Katiyar and H. Mukhtar (1996) Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int. J. Oncol. 8 221-238.
16. K. Kida, M. Suzuki, N. Matsumoto, et al. (2000) Identification of biliary metabolites of (−)-epigallocatechin gallate in rats. J. Agric Food Chem. 48 4151-4155.
17. G. Kuhnle, J.P. Spencer, H. Schroeter, et al. (2000) Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun. 277 507-512.
18. M.J. Lee, Z.Y. Wang, H. Li, et al. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4 393-399.
19. C. Li, M.J. Lee, S. Sheng, et al. (2000) Stuctural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 13 177-184.
20. H. Lu, X. Meng, C. Li, et al. (2003) Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab. Dispos. 31 452-461.
21. X.F. Meng, M.J. Lee, C. Li, et al. (2001) Formation and identification of 4’-O-methyl-(−)-epigallocatechin in humans. Drug Metab. Dispo. 29 789-793.
22. V. Meunier, M. Bourrié, Y. Berger and G. Fabre (1995) The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetic application. Cell Biol. Toxicol. 11 187-194.
23. M. Natsume, N. Osakabe, M. Oyama, et al. (2003) Structures of (−)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (−)-epicatechin: differences between human and rat. Free Radic. Biol. Med. 34 840-849.
24. K. Okushio, N. Atsmoto, M. Suzuki, et al. (1996) Absorption of tea catechins into rat portal vein. Biol. Pharm. Bull. 19 326-329.
25. K. Okushio, M. Suzuki, N. Matsumoto, et al. (1999) Identification of (–) epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispo. 27 309-316.
26. K. Okushio, M. Suzuki, N. Matsumoto, et al. (1999) Methylation of tea catechins by rat liver homogenates. Biosci. Biotechnol. Biochem. 63 430-432.
27. M.K. Piskula and J. Terao (1998) Accumulation of (−)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr. 128 1172-1178.
28. I.R. Record and J.M. Lane (2001) Simulated intestinal digestion of green tea and black teas. Food Chemistry 73 481-486.
29. S. Sang, X. Cheng, R.E. Stark, et al. (2002) Chemical studies on antioxidant mechanism of tea catechins: analysis of radical reaction products of catechin and epicatechin with 2,2-diphenyl-1-picrylhydrazyl. Bioorgan Med. Chem. 10 2233-2237.
30. H. Suzuki and Y. Sugiyama (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12 3-12.
31. Y. Takehiko and K. Mujo (1997) Chemistry and applications of green tea. New York: CRC Press pp. 1–130
32. Y. Takizawa, T. Morota, S. Takeda and M. Aburada (2003) Pharmacokinetics of (−)-epicatechin-3-O-gallate, an active component of Onpi-to, in rats. Biol. Pharm. Bull. 26 608-612.
33. J.B. Vaidyanathan and T. Walle (2001) Transport and metabolism of the tea flavonoid (−)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res. 18 1420-1425.
34. J.B. Vaidyanathan and T. Walle (2002) Glucuronidation and sulfation of the tea flavonoid (−)-epicatechin by the human and rat enzymes. Drug Metab. Dispos. 30 897-903.
35. J.B. Vaidyanathan and T. Walle (2003) Cellular uptake and efflux of the tea flavonoid (–)epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 307 745-752.
36. J.M. Van Amelsvoort, K.H. Van Hof, J.N. Mathot, et al. (2001) Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica 31 891-901.
37. T. Walle, Y. Otake, U.K. Walle and F.A. Wilson (2000) Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J. Nutr. 130 2658-2661.
38. B.A. Warden, L.S. Smith, G.R. Beecher, et al. (2001) Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 131 1731-1737.
39. C.S. Yang, L. Chen, M. Lee, et al. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7 351-354.
40. C.S. Yang, J.M. Landau, M.T. Huang and H.L. Newmark (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Ann. Rev. Nutr. 21 381-406.
41. K. Yoshino, M. Suzuki, K. Sasaki, et al. (1999) Formation of antioxidants from (−)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma. J. Nutr. Biochem. 10 223-229.
42. J.F. Young, L.O. Dragsted, J. Haraldsdottir, et al. (2002) Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet. Br. J. Nutr. 87 343-355.
43. L. Zhang, S.S. Chow and Z. Zuo (2006) Effect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea polyphenols in Caco-2 monolayer model. J. Pharm. Pharmcol. 58 37-44.
44. L. Zhang, Y. Zheng, M.S. Chow and Z. Zuo (2004) Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287 1-12.
45. M. Zhu, Y. Chen and R.C. Li (2000) Oral absorption and bioavailability of tea catechins. Planta Med. 66 444-447.
46. Q.Y. Zhu, Y. Zhang, D. Tsang, et al. (1997) Stability of green tea catechins. J. Agric. Food Chem. 45 4624-4628.